Search

everythinglearnresearchcommunity

for

Search:↓

A certain gene variation is linked to a higher risk of polycystic ovarian syndrome in South Indian women.

Children with classic congenital adrenal hyperplasia have thicker heart fat and are at higher risk for heart problems and early atherosclerosis.

Polycystic Ovarian Syndrome is common in overweight urban college girls and may increase the risk of heart and metabolic problems.

Metabolic syndrome in kids and teens is linked to obesity and increases diabetes and heart disease risk; early lifestyle changes are crucial for management.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

The guidelines suggest lifestyle changes, diet adjustments, and personalized medication to manage dyslipidemia and reduce heart disease risk.

Cinnamon may help manage obesity and improve conditions related to Polycystic Ovary Syndrome (PCOS).

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Men with hair loss have higher BMI, waist size, blood pressure, and are linked to smoking and inactivity.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

The document concludes that more research is needed to understand hair loss in men and to find new treatments.

High Lipid Accumulation Product levels are linked to more hirsutism in women with Polycystic Ovary Syndrome.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Early-onset hair loss in young males is linked to a higher risk of metabolic syndrome.

The study suggests that treating early hair loss with Nourkrin® with Marilex® can help prevent further hair loss and may be linked to reducing the risk of lifestyle diseases.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.